FDA Inspection
Octapharma ABOctapharma AB – FDA Inspection, Sep 28, 2018
Record Details
This FDA Inspection record concerns Octapharma AB, with an inspection on September 28, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d1bd9bce-fbba-4979-be9f-74a49e7eed87
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1070173
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma AB
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 3, 2016 | Not classified | Office of Inspections and Investigations | |
| April 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2011 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma AB
- FDA Inspection 1218250 - 2023-09-19
- FDA Inspection 994537 - 2016-10-03
- FDA Inspection 894095 - 2014-04-28
- FDA Inspection 783783 - 2012-01-19
- FDA Inspection 710676 - 2011-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.